# Kronos Worldwide, Inc. (KRO)

> Source: Nexqual · https://nexqual.com/KRO · data as of 2026-10-29 20:00 UTC · cite as "Nexqual, Kronos Worldwide, Inc. (KRO), nexqual.com/KRO" · informational, not investment advice.

**Price:** USD 7.45 (-3.25% on the day) · last close of Oct 29, 2026; US market closed, not a live price. Prev close 7.7 · day 7.38–7.73 · 52w 4.08–9.17 · market cap $857M · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $1.94B, net income -$109M (-5.6% margin) (SEC filings).
- Analysts: Hold (mean 3.00 on a 1–5 scale) (2 analysts), mean target USD 8.5 (range 8–9).
- Total return with dividends: 1Y +65.9% vs S&P 500 +14.8%; 5Y -26.3% vs S&P 500 +79.1%.
- Next earnings: 2026-11-05, EPS estimate USD 0.19, revenue estimate $537M. All companies reporting that day: https://nexqual.com/earnings/2026-11-05
- Dividend: USD 0.2 a year (yield 2.60%), paid quarterly; latest ex-dividend date 2026-09-03; annual dividends fell 35.9% a year 2022–2025.
- Short interest: 5.10% of float (as of 2026-10-15), 3.0 days to cover.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.94B | $1.93B | $1.67B | $1.89B | $1.86B | $1.94B |
| Gross profit | $446M | $391M | $165M | $359M | $213M | — |
| Operating income | $187M | $160M | -$56.0M | $123M | -$36.5M | -$32.1M |
| Net income | $113M | $105M | -$49.1M | $86.2M | -$111M | -$109M |
| EPS (diluted) | $0.98 | $0.90 | -$0.43 | $0.75 | -$0.96 | — |
| Free cash flow | $148M | $18.5M | -$41.9M | $43.0M | -$40.4M | — |
| Gross margin | 23.0% | 20.3% | 9.9% | 19.0% | 11.5% | — |
| Operating margin | 9.6% | 8.3% | -3.4% | 6.5% | -2.0% | -1.7% |
| Net margin | 5.8% | 5.4% | -2.9% | 4.6% | -6.0% | -5.6% |
| Revenue growth | +18.3% | -0.5% | -13.7% | +13.2% | -1.5% | — |
| Cash + short-term investments | $406M | $328M | $195M | $107M | $33.2M | — |
| Total debt | $451M | $425M | $441M | $507M | $557M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/S 0.4x · EV/EBITDA 45.8x · EV/Sales 0.7x · P/B 1.1x · Earnings yield -12.76% · Dividend yield (paid, TTM) 2.68% · Net debt $543M · EV $1.40B
P/E at fiscal year-ends: Dec 2024 13.0x.

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 2 analysts; mean target USD 8.5 (low 8, high 9).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-25 | Deutsche Bank | Target raised | Buy | $6 → $9 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-30) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +65.9% | -26.3% |
| S&P 500 (SPY) | +14.8% | +79.1% |
| Per year | +66.4% | -5.9% |
| Volatility (annualized) | 58.6% | 47.3% |
| Max drawdown | -26.5% (Feb 2026→Mar 2026) | -72.2% (May 2022→Nov 2025) |

## Dividends
Annual dividend rate USD 0.20 per share, yield 2.60% at the current price. Paid over the last 12 months: USD 0.20 in 4 payments (quarterly).
Most recent ex-dividend date: Sep 3, 2026; payment date: Sep 17, 2026. To receive a dividend, shares must be owned before the ex-dividend date.
Latest change: cut 73.7% to USD 0.05 per payment from USD 0.19, starting with the Sep 6, 2024 ex-dividend date.
Payout ratio 34% of earnings · 5-year average yield 4.84% · annual dividends fell 35.9% a year from 2022 to 2025.
| Ex-dividend date | Amount per share |
|---|---|
| 2026-09-03 | USD 0.05 |
| 2026-06-04 | USD 0.05 |
| 2026-03-10 | USD 0.05 |
| 2025-11-21 | USD 0.05 |
| 2025-09-05 | USD 0.05 |
| 2025-06-09 | USD 0.05 |
| 2025-03-11 | USD 0.05 |
| 2024-11-29 | USD 0.05 |
Total by calendar year: 2022 USD 0.76 · 2023 USD 0.76 · 2024 USD 0.48 · 2025 USD 0.20.

## Short interest
1,099,643 shares sold short, 5.10% of the float, as of Oct 15, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 15, 2026): 1,079,765 shares (+1.8%). Days to cover: 3.0 (short shares ÷ average daily volume).

## Peers (Specialty Chemicals)
BCPC (Balchem Corporation) USD 170.4 +2.47% · SXT (Sensient Technologies Corporati) USD 131.53 -0.05% · AXTA (Axalta Coating Systems Ltd.) USD 33.61 -2.97% · EMN (Eastman Chemical Company) USD 67.93 +1.89% · NEU (NewMarket Corp) USD 803.07 -8.04% · WLK (Westlake Corporation) USD 66.01 +0.27%

## More
Full page: https://nexqual.com/KRO · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.19 | $0.04 | +380.1% | $537.3M | 2 |
| Next quarter (ends 2026-12-31) | $0.12 | $0.00 | +$0.12 | $459.8M | 2 |
| Current fiscal year (ends 2026-12-31) | $0.40 | $-0.08 | +$0.48 | $2.06B | 2 |
| Next fiscal year (ends 2027-12-31) | $0.61 | $0.42 | +46.1% | $2.10B | 2 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-11-05): ±12.4%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 22 | 62.2% | ±12.4% |
| 2027-02-19 | 113 | 58.2% | ±25.8% |

## Earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | $0.13 | $0.07 | Beat +85.7% | — |
| — | Quarter ended Mar 31, 2026 | −$0.04 | −$0.12 | Beat +66.7% | — |
| — | Quarter ended Dec 31, 2025 | −$0.72 | −$0.23 | Miss −213.0% | — |
| — | Quarter ended Sep 30, 2025 | −$0.32 | −$0.06 | Miss −433.3% | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).